London Healthtech Startup Digistain Named EIT Venture Award Finalist for AI Cancer Diagnostics Innovation

The European Institute of Innovation and Technology (EIT) announced the nine finalists for its 2026 awards. Digistain, a UK‑based healthtech startup founded in 2020 by Dr. Hemmel Amrania, was nominated by EIT Health for the Venture Award. The company has developed an AI‑based platform that analyses tumour samples to assess individual breast‑cancer risk and guide early chemotherapy decisions. As a finalist, Digistain will compete in Budapest on 2 December 2026 for a cash prize of up to €50,000.